Rikke C Nielsen
CEO BEO Therapeutics
Seminars
Thursday 29th January 2026
Update on BEO 001 Clinical Proof-of-Concept Study
11:30 am
- Ongoing clinical trial in 99 patients to evaluate BEO 001 efficacy and safety
- Predictive response model predicting clinical efficacy
